| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| GILD 吉利德科學 | 165,071,131,561.3 | 157,301,149,797.64 | 106,845,445,433.62 |
| MRK 默克藥廠 | 215,002,280,194.44 | 180,906,157,687.24 | 90,518,648,309.98 |
| BMY 施貴寶 | 137,072,969,425.58 | 125,795,021,211.66 | 27,932,592,669.36 |
| 6620 漢達 | 264,222,000 | 261,998,000 | 470,802,000 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 6467 泰合 | -46,460,000 | -47,087,000 | -47,426,000 |
| 4166 友霖 | 52,806,000 | 22,052,000 | -81,478,000 |
| 6589 台康生技 | -68,004,000 | -242,795,000 | -398,591,000 |
| NVO 諾和諾德 | 207,319,279,606.38 | 139,327,900,423.07 | -1,645,233,314.55 |
| TEVA Teva Pharmaceutical Industries Limited | 13,507,310,070.16 | 10,064,913,086.26 | -2,819,487,053.48 |
| AMGN 美國安進 | 139,040,053,416.38 | 119,795,415,039.72 | -26,195,001,810.82 |
| JNJ 嬌生 | 253,098,140,149.6 | 208,445,333,558.44 | -115,139,982,928.16 |
載入數據中...
和藥價與專利壓力相關的產業概念股
藥價與專利壓力概念股相關指標排名
藥價與專利壓力每月營收
藥價與專利壓力每股盈餘
藥價與專利壓力每股淨值
藥價與專利壓力損益表
藥價與專利壓力總資產
藥價與專利壓力負債和股東權益
藥價與專利壓力現金流量表
藥價與專利壓力利潤比率
藥價與專利壓力營業費用率拆解
藥價與專利壓力杜邦分析
藥價與專利壓力ROE / ROA
藥價與專利壓力經營週轉能力
藥價與專利壓力營運週轉天數
藥價與專利壓力現金股利發放率
藥價與專利壓力財務結構比率
藥價與專利壓力流速動比率
藥價與專利壓力利息保障倍數
藥價與專利壓力現金流量分析
藥價與專利壓力營業現金流對淨利比
藥價與專利壓力盈餘再投資比率
藥價與專利壓力月營收成長率
藥價與專利壓力營收成長率
藥價與專利壓力毛利成長率
藥價與專利壓力營業利益成長率
藥價與專利壓力稅後淨利成長率
藥價與專利壓力每股盈餘成長率
藥價與專利壓力本益比評價
藥價與專利壓力股價淨值比評價
藥價與專利壓力現金股利殖利率
藥價與專利壓力平均現金股息殖利率
藥價與專利壓力董監持股比例
藥價與專利壓力董監持股質押比例